Related Experiment Video
Updated: Jun 22, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus infection and the risk of coronary disease
Adeel A Butt1, Wang Xiaoqiang, Matthew Budoff
1VA Pittsburgh Healthcare System, University of Pittsburgh School of Medicine, Center for Health Equity Research and Promotion, Pittsburgh, Pennsylvania, USA. butta@dom.pitt.edu
Insights
Hepatitis C virus (HCV) infection is linked to a higher risk of coronary artery disease (CAD), even in younger patients with fewer traditional risk factors. This study quantifies the increased CAD risk associated with HCV infection.
Area of Science:
- Cardiology
- Hepatology
- Epidemiology
Background:
- The relationship between hepatitis C virus (HCV) infection and coronary artery disease (CAD) remains debated.
- Previous studies have yielded conflicting results regarding this association.
Purpose of the Study:
- To investigate and quantify the association between HCV infection and the risk of developing CAD.
- To determine if HCV infection independently increases CAD risk after accounting for other factors.
Main Methods:
- Utilized the "Electronically Retrieved Cohort of HCV Infected Veterans" database, a national observational cohort.
- Included 82,083 HCV-infected and 89,582 HCV-uninfected veteran subjects.
- Employed Cox proportional-hazards models to assess CAD risk.
Main Results:
- HCV-infected subjects exhibited lower cholesterol and triglyceride levels but higher rates of substance abuse, renal failure, and anemia.
- Multivariable analysis revealed HCV infection was associated with a 25% increased risk of CAD (HR, 1.25; 95% CI, 1.20-1.30).
- Traditional CAD risk factors like hypertension and diabetes impacted risk in both groups.
Conclusions:
- HCV-infected individuals present with a seemingly favorable risk profile (younger, lower lipids, less hypertension).
- Despite this, HCV infection independently elevates the risk of coronary artery disease.
- Findings highlight the importance of considering HCV status in cardiovascular risk assessment.
Background:
The association between hepatitis C virus (HCV) infection and coronary artery disease (CAD) is controversial. We conducted this study to determine and quantify this association.
Methods:
We used an established, national, observational cohort of all HCV-infected veterans receiving care at all Veterans Affairs facilities, the Electronically Retrieved Cohort of HCV Infected Veterans, to identify HCV-infected subjects and HCV-uninfected control subjects. We used the Cox proportional-hazards model to determine the risk of CAD among HCV-infected subjects and control subjects.
Results:
We identified 82,083 HCV-infected and 89,582 HCV-uninfected subjects. HCV-infected subjects were less likely to have hypertension, hyperlipidemia, and diabetes but were more likely to abuse alcohol and drugs and to have renal failure and anemia. HCV-infected subjects had lower mean (+/- standard deviation) total plasma cholesterol (175 +/- 40.8 mg/dL vs. 198 +/- 41.0 mg/dL), low-density lipoprotein cholesterol (102 +/- 36.8 mg/dL vs. 119 +/- 38.2 mg/dL), and triglyceride (144 +/- 119 mg/dL vs. 179 +/- 151 mg/dL) levels, compared with HCV-uninfected subjects (P < .001 for all comparisons). In multivariable analysis, HCV infection was associated with a higher risk of CAD (hazard ratio, 1.25; 95% confidence interval, 1.20-1.30). Traditional risk factors (age, hypertension, chronic obstructive pulmonary disease, diabetes, and hyperlipidemia) were associated with a higher risk of CAD in both groups, whereas minority race and female sex were associated with a lower risk of CAD.
Conclusions:
HCV-infected persons are younger and have lower lipid levels and a lower prevalence of hypertension. Despite a favorable risk profile, HCV infection is associated with a higher risk of CAD after adjustment for traditional risk factors.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Coronary Artery Disease I: Introduction
Cytomegalovirus Disease
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
